Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 1, 2007Journal of Clinical OncologyOpen Access

Donor Lymphocyte Infusion in the Treatment of First Hematological Relapse After Allogeneic Stem-Cell Transplantation in Adults With Acute Myeloid Leukemia: A Retrospective Risk Factors Analysis and Comparison With Other Strategies by the EBMT Acute Leukemia Working Party

View Full Paper
Ask AI
Bookmark
Share

Authors

CSChristoph SchmidAugsburg UniversityMLMyriam LabopinInsermArnon NaglerArnon NaglerGoethe University Frankfurt

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Schmid et al. (2007) studied this question.

synapsesocial.com/papers/6a19d43a407564563bf6995ehttps://doi.org/10.1200/jco.2007.11.6053
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Second Allogeneic Bone Marrow Transplantation in Acute Leukemia: Results of a Survey by the European Cooperative Group for Blood and Marrow Transplantation2001 · 187 citations
  2. 2Treatment of Relapsed Acute Leukemia after Allogeneic Transplantation: A Single Center Experience2007 · 98 citations
  3. 3Nonparametric Estimation from Incomplete Observations1958 · 39,556 citations
  4. 4Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.1997 · 1,263 citations
  5. 5Second transplants for leukaemic relapse after bone marrow transplantation: high early mortality but favourable effect of chronic GVHD on continued remission. A REPORT BY THE EBMT LEUKAEMIA WORKING PARTY1991 · 108 citations